André Nieoullon

3.2k total citations
78 papers, 2.7k citations indexed

About

André Nieoullon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, André Nieoullon has authored 78 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Cellular and Molecular Neuroscience, 26 papers in Molecular Biology and 15 papers in Physiology. Recurrent topics in André Nieoullon's work include Neuroscience and Neuropharmacology Research (39 papers), Neurotransmitter Receptor Influence on Behavior (26 papers) and Receptor Mechanisms and Signaling (16 papers). André Nieoullon is often cited by papers focused on Neuroscience and Neuropharmacology Research (39 papers), Neurotransmitter Receptor Influence on Behavior (26 papers) and Receptor Mechanisms and Signaling (16 papers). André Nieoullon collaborates with scholars based in France, United States and Canada. André Nieoullon's co-authors include Lydia Kerkerian‐Le Goff, Nicole Dusticier, A. Chéramy, Jacques Glowinski, Antoine Coquerel, Olivier Bosler, Marianne Amalric, Claude Forni, M. Errami and F. Masmejean and has published in prestigious journals such as Science, Brain Research and Annals of the New York Academy of Sciences.

In The Last Decade

André Nieoullon

77 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
André Nieoullon France 33 1.9k 924 542 466 282 78 2.7k
Vincent Leviel France 33 2.3k 1.2× 1.2k 1.3× 580 1.1× 534 1.1× 282 1.0× 78 3.4k
Sture Liljequist Sweden 34 2.4k 1.3× 1.3k 1.4× 233 0.4× 514 1.1× 386 1.4× 107 3.4k
Matthew P. Galloway United States 35 1.9k 1.0× 1.2k 1.3× 438 0.8× 520 1.1× 362 1.3× 86 3.5k
Edward G. Meloni United States 26 1.5k 0.8× 887 1.0× 527 1.0× 651 1.4× 274 1.0× 37 2.7k
Marc Marien France 32 1.5k 0.8× 803 0.9× 671 1.2× 343 0.7× 343 1.2× 48 2.6k
H. Hällman Sweden 23 1.6k 0.9× 830 0.9× 530 1.0× 193 0.4× 428 1.5× 38 2.5k
Gerald D. Frye United States 28 2.1k 1.1× 1.1k 1.2× 243 0.4× 495 1.1× 273 1.0× 88 2.9k
R.J. Boegman Canada 31 1.3k 0.7× 929 1.0× 248 0.5× 591 1.3× 377 1.3× 104 2.6k
Hideho Higashi Japan 33 2.3k 1.2× 1.8k 1.9× 240 0.4× 414 0.9× 630 2.2× 93 3.3k
Maria Rosaria Domenici Italy 29 1.4k 0.7× 712 0.8× 349 0.6× 301 0.6× 208 0.7× 78 2.3k

Countries citing papers authored by André Nieoullon

Since Specialization
Citations

This map shows the geographic impact of André Nieoullon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by André Nieoullon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites André Nieoullon more than expected).

Fields of papers citing papers by André Nieoullon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by André Nieoullon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by André Nieoullon. The network helps show where André Nieoullon may publish in the future.

Co-authorship network of co-authors of André Nieoullon

This figure shows the co-authorship network connecting the top 25 collaborators of André Nieoullon. A scholar is included among the top collaborators of André Nieoullon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with André Nieoullon. André Nieoullon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nieoullon, André. (2011). Neurodegenerative diseases and neuroprotection: current views and prospects. Journal of Applied Biomedicine. 9(4). 173–183. 43 indexed citations
4.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Neuroprotection: Present and future. Therapies. 62(6). 473–476. 2 indexed citations
5.
Nafia, Imane, Diane B. Ré, F. Masmejean, et al.. (2007). Preferential vulnerability of mesencephalic dopamine neurons to glutamate transporter dysfunction. Journal of Neurochemistry. 105(2). 484–496. 32 indexed citations
6.
Bordet, Régis, Pierre Lestage, Philippe Bouhours, et al.. (2007). Des agents neuroprotecteurs au concept de traitement modulateur du cours évolutif des maladies cérébrales. Therapies. 62(6). 463–472. 1 indexed citations
7.
Nieoullon, André, et al.. (2006). The neuronal excitatory amino acid transporter EAAC1/EAAT3: does it represent a major actor at the brain excitatory synapse?. Journal of Neurochemistry. 98(4). 1007–1018. 113 indexed citations
8.
Dusticier, Nicole, et al.. (2006). Adaptive changes in serotonin neurons of the raphe nuclei in 5‐HT4 receptor knock‐out mouse. European Journal of Neuroscience. 24(4). 1053–1062. 60 indexed citations
9.
Turle-Lorenzo, N., Carole Puma, Philippe Morain, et al.. (2006). The Dopamine Agonist Piribedil with L-DOPA Improves Attentional Dysfunction: Relevance for Parkinson’s Disease. Journal of Pharmacology and Experimental Therapeutics. 319(2). 914–923. 35 indexed citations
10.
Sellal, François, André Nieoullon, Bernard François Michel, et al.. (2005). Pharmacology of Alzheimer’s Disease: Appraisal and Prospects. Dementia and Geriatric Cognitive Disorders. 19(5-6). 229–245. 6 indexed citations
11.
Sellal, François, André Nieoullon, Bernard‐François Michel, et al.. (2005). Pharmacologie de la maladie d’Alzheimer : vision du futur. Therapies. 60(2). 89–107. 3 indexed citations
12.
Salin, Pascal, Gustavo Dziewczapolski, Oscar S. Gershanik, André Nieoullon, & Rita Raisman‐Vozari. (1997). Differential regional effects of long-term l-DOPA treatment on preproenkephalin and preprotachykinin gene expression in the striatum of 6-hydroxydopamine-lesioned rat. Molecular Brain Research. 47(1-2). 311–321. 22 indexed citations
13.
Ouagazzal, Abdel‐Mouttalib, André Nieoullon, & Marianne Amalric. (1994). Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum. European Journal of Pharmacology. 251(2-3). 229–236. 58 indexed citations
14.
Goff, Lydia Kerkerian‐Le, et al.. (1992). Intracerebroventricular administration of neuropeptide Y affects parameters of dopamine, glutamate and GABA activities in the rat striatum. Brain Research Bulletin. 28(2). 187–193. 50 indexed citations
15.
Nieoullon, André & Lydia Kerkerian‐Le Goff. (1992). Cellular interactions in the striatum involving neuronal systems using “classical” neurotransmitters: Possible functional implications. Movement Disorders. 7(4). 311–325. 61 indexed citations
16.
Apicella, Paul, Eric Legallet, André Nieoullon, & Elisabeth Trouche. (1991). Neglect of contralateral visual stimuli in monkeys with unilateral striatal dopamine depletion. Behavioural Brain Research. 46(2). 187–195. 30 indexed citations
17.
Salin, Pascal, et al.. (1990). Somatostatin-immunoreactive neurons in the rat striatum: effects of corticostriatal and nigrostriatal dopaminergic lesions. Brain Research. 521(1-2). 23–32. 50 indexed citations
18.
Vercher, Jean‐Louis, et al.. (1990). Pyridostigmine-induced inhibition of blood acetylcholinesterase (AChE) and resulting effects on manual ocular tracking performance in the trained baboon. Behavioral and Neural Biology. 53(3). 411–427. 1 indexed citations
19.
Vuillet, J., Lydia Kerkerian‐Le Goff, Pascal Salin, & André Nieoullon. (1989). Ultrastructural features of NPY-containing neurons in the rat striatum. Brain Research. 477(1-2). 241–251. 59 indexed citations
20.
Errami, M. & André Nieoullon. (1988). α‐[3H]Amino‐3‐Hydroxy‐5‐Methyl‐4‐Isoxazolepropionic Acid Binding to Rat Striatal Membranes: Effects of Selective Brain Lesions. Journal of Neurochemistry. 51(2). 579–586. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026